Ketorolac Tromethamine Injection, Solution
Product Images NDC 31722-307

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 31722-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolacinj15mg1mlcarton (Ketorolacinj15mg1mlcarton)

FDA Label Image

Ketorolacinj15mg1mlvial (Ketorolacinj15mg1mlvial)

This is a description of a medication called Ketorolac Tromethamine Injection. The medication is available in a 15 mg/mL concentration and is intended for intravenous or intramuscular use. It comes in a 1 mL single-dose vial. The medication is manufactured by ASPIRO PHARMA LIMITED in India and distributed by Camber Pharmaceuticals, Inc. There is a lot number and expiration date provided, but the text for these details is not readable.*

FDA Label Image

Ketorolacinj30mg1mlcarton (Ketorolacinj30mg1mlcarton)

FDA Label Image

Ketorolacinj30mg1mlvial (Ketorolacinj30mg1mlvial)

FDA Label Image

Ketorolacinj60mg2mlcarton (Ketorolacinj60mg2mlcarton)

FDA Label Image

Ketorolacinj60mg2mlvial (Ketorolacinj60mg2mlvial)

FDA Label Image

Ketorolactromethaminefigura1 (Ketorolactromethaminefigura1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.